| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |